Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SAP vs GSK✓SelectedUSD · GSKSAP vs GSK performance historyLatest closeAs of+0.36%11/13
Stock and ETF performance explorer

SAP vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+68.4%
GSK return
+65.8%
Excess return
+2.5%
Maximum drawdown
-52.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.4%+0.5%-0.2%+0.3%
7D+0.6%+1.1%-0.5%+0.4%
30D+6.5%+6.3%+0.2%+5.3%
3M+12.2%+1.8%+10.4%+11.7%
6M+46.1%+1.7%+44.4%+45.5%
YTD-1.6%+6.5%-8.2%-3.5%
1Y-5.1%+9.5%-14.6%-7.5%
3Y+68.4%+65.3%+3.1%+53.2%
All+68.4%+65.8%+2.5%+53.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling